BHMP
SRDX

Bardin Hill Management Partners’s Surmodics SRDX Stock Holding History

Bardin Hill Management Partners’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-187,869
Closed -$7.44M – 41
2024
Q4 		$7.44M Buy
+187,869
New +$7.31M 3.53% 10

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bardin Hill Management Partners's SRDX Position: Q1 2025 in Review

Bardin Hill Management Partners sold out of Surmodics (SRDX) in Q1 2025, closing a stake of 187,869 shares — an estimated $7.44M sold.

Bardin Hill Management Partners first reported a position in SRDX in Q4 2024 and held it in 1 quarter. The position peaked at $7.44M in Q4 2024. 135 funds tracked by Wall St. Rank hold SRDX as of Q1 2025.

  • Bardin Hill Management Partners reported no remaining Surmodics position as of Q1 2025 after selling out during the quarter.
  • Bardin Hill Management Partners sold 187,869 Surmodics shares in Q1 2025, an estimated $7.44M.
  • Bardin Hill Management Partners first reported a position in Surmodics in Q4 2024 and held it in 1 quarter.
  • Bardin Hill Management Partners's Surmodics position peaked at $7.44M in Q4 2024.
  • 135 funds tracked by Wall St. Rank held Surmodics as of Q1 2025.

Based on Bardin Hill Management Partners's 13F filing for Q1 2025, filed 15 May 2025.